Epidemiology of Acute Respiratory Distress Syndrome in Chinese ICUs
1 other identifier
observational
2,530
1 country
26
Brief Summary
The acute respiratory distress syndrome(ARDS)has a high morbidity and mortality in patients admitted to intensive care units(ICUs). It represents a significant public health issue. No large nationwide, multicenters study of ARDS has been conducted in China. The purposes of this study are to analyse: 1)the incidence and outcomes of ARDS in ICU; 2) factors associated the mortality ; and 3) risk factors for development of ARDS .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2015
Shorter than P25 for all trials
26 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2015
CompletedFirst Submitted
Initial submission to the registry
May 18, 2015
CompletedFirst Posted
Study publicly available on registry
July 3, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2015
CompletedJune 16, 2020
January 1, 2015
7 months
May 18, 2015
June 13, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
incidence of acute respiratory distress syndrome (ARDS)
incidence of ARDS = the number of patients developing ARDS during ICU / the total number of patients admitted to ICU
from ICU admission to 28-day of ICU stay
Secondary Outcomes (2)
ICU mortality of patients with ARDS
followed up to 3 months after inclusion or to ICU discharge, whichever occurred first
hospital mortality of patients with ARDS
followed up to 3 months after inclusion or to hospital discharge, whichever occurred first
Study Arms (1)
ARDS, non-ARDS
patients with ARDS and patients without ARDS
Eligibility Criteria
All patients admitted to the participating ICUs during a 6-month period(from January 1, 2015 to July 1,2015 )
You may qualify if:
- all patients age \>18 yrs admitted to 24 participating ICUs
You may not qualify if:
- No patients should be excluded (regardless of age, underlying disease, life expectancy, etc).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (26)
MICU, Peking union medical college hospital
Beijing, Beijing Municipality, 100730, China
Beijing Hospital of ministry of Health
Beijing, Beijing Municipality, China
Department of Critical Care Medicine, Fuxing Hospital, Capital Medical University
Beijing, Beijing Municipality, China
General ICU, Beijing Tongren Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Peking University People's Hospital
Beijing, Beijing Municipality, China
China-Japan Friendship Hospital
Beijng, Beijing Municipality, China
Department of Emergency and Intensive Care Medicine, The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
The First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China
Department of CriticalCare Medicine, Guangdong General Hospital
Guangzhou, Guangdong, China
Department of Critical Care Medicine, Hainan Provincial People's Hospital
Haikou, Hainan, China
Department of Critical Care Medicine, Hebei Medical University Fourth Hospital
Shijiazhuang, Hebei, China
Department of Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China
ICU, The First Affiliated Hospital, Zhengzhou University
Zhengzhou, Henan, China
Department of Critical Care Medicine, Tongji Hospital of Tongji Medical College, Huazhong University of Science & Technology
Wuhan, Hubei, China
Department of Critical Care Medicine, Xiangya Hospital, Central South University
Changsha, Hunan, China
Department of Critical Care Medicine, The Affiliated Hopsital of Inner Mongolia Medical University
Hohhot, Inner Mongolia, China
Department of Critical Care Medicine, The Second Hospital of Jilin University
Changchun, Jilin, China
Department of Critical Care Medicine, The First Affiliated Hospital of China Medical University
Shenyang, Liaoning, China
General Hospital of Ningxia Medical University
Yinchuan, Ningxia, China
Department of Critical Care Medicine, Qilu Hospital of Shandong University
Jinan, Shandong, China
Emergency ICU, Ruijin Hospital, Shanghai Jiao Tong University
Shanghai, Shanghai Municipality, China
Surgical Intensive Care Unit, Xijing Hospital
XiAn, Shanxi, China
Department of Critical Care Medicine, West China Hospital, Sichuan University
Chengdu, Sichuan, China
Department of Critical Care Medicine, First Affiliated Hospital, Xinjiang Medical University
Ürümqi, Xinjiang, China
Department of Emergency Medicine and Medical ICU, The First Affiliated Hospital of Kunming Medical University
Kunming, Yunnan, China
Department of Critical Care Medicine, Zhejiang Provincial People's Hospital
Hangzhou, Zhejiang, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bin Du
MICU of Peking Union Medical College Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 18, 2015
First Posted
July 3, 2015
Study Start
January 1, 2015
Primary Completion
August 1, 2015
Study Completion
December 1, 2015
Last Updated
June 16, 2020
Record last verified: 2015-01